In a Cancer Research UK funded study, scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test for detecting circulating tumor DNA can help in predicting lung…
Category: Lung Cancer News
New Test Oracle To Predict Survival in Early-Stage Lung Cancer
Researchers at the Francis Crick Institute and University College London Cancer Institute have demonstrated that ORACLE test can better predict clinical outcomes for patients with early-stage lung cancer in comparison with other…
Metformin Appears To Fight Lung Cancer But Only In Overweight Patients
Metformin is a common drug prescribed for patients with Type 2 patients to lower their blood sugar. It is a FDA approved drug since 1995 and is used by about 20 million…
FDA Approves New Drug for Lung Cancer
Lung cancer is one of the leading causes behind cancer related deaths. Various studies and research works are going on to help lung cancer patients to get cure from this disease. Time-to-time,…
Simple Urine Test for Early Detection of Lung Cancer
Scientists have developed a world-first urine test to indicate the possible signs of lung cancer. This urine test has been developed by Cambridge scientists and is said to be first of its…
Lung Cancer Screening : What to Expect
According to National Cancer Institute of US, lung cancer is the most common cause of cancer deaths in the country. One of the vital factors that contribute towards its survival is early…
Tarlatamab for Small Cell Lung Cancer
Lung cancer is the second most form of cancers and remains the leading cause of cancer deaths. A variety of new treatments are helping to bring down the number of deaths from…
UK Study Shows Ethic And Social Inequalities In Diagnosis Of Lung Cancer
The most comprehensive UK study ever conducted of lung cancer diagnosis has revealed significant disparities among ethnic groups. It has found evidences that people living in most deprived areas were diagnosed with…
Study: Physical Tests Vital in Treating Metastatic Lung Cancer
According to a new study from the researchers in Brazil and the United States, simple physical tests like sitting down, standing up and walking can significantly aid physicians in managing treatments for…
FDA Approves Optune Luna for Metastatic NSCLC
U.S. based FDA has approved Optune Lua for concurrent use with PD-1/PD-L1 inhibitors for treatment of patients with metastatic non-small cell lung cancer and whose disease has progressed on or after platinum-based…
Research Finds Useful Information about Natural Killer Cells
The researchers of Trinity College Dublin based at St James’s Hospital have provided useful insights about the behaviour and metabolic function of *natural killer* immune cell resident in the lungs. Their findings…
Hetronifly Recommended for Lung Cancer in European Markets
The Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion and recommended for grant of marketing authorization for the medicinal product, Hetronifly in European markets. It is intended…